1 July 2023 false No description of principal activity Taxfiler 2024.6 06837467business:PrivateLimitedCompanyLtd2023-07-012024-06-30 068374672023-06-30 068374672023-07-012024-06-30 06837467business:AuditExempt-NoAccountantsReport2023-07-012024-06-30 06837467business:FilletedAccounts2023-07-012024-06-30 068374672024-06-30 06837467business:Director12023-07-012024-06-30 06837467business:Director22023-07-012024-06-30 06837467business:RegisteredOffice2023-07-012024-06-30 068374672023-06-30 06837467core:WithinOneYear2024-06-30 06837467core:WithinOneYear2023-06-30 06837467core:ShareCapitalcore:PreviouslyStatedAmount2024-06-30 06837467core:ShareCapitalcore:PreviouslyStatedAmount2023-06-30 06837467core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-06-30 06837467core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-06-30 06837467core:PreviouslyStatedAmount2024-06-30 06837467core:PreviouslyStatedAmount2023-06-30 06837467business:SmallEntities2023-07-012024-06-30 06837467countries:EnglandWales2023-07-012024-06-30 06837467core:LandBuildings2023-07-012024-06-30 06837467core:FurnitureFittings2023-07-012024-06-30 06837467core:ComputerEquipment2023-07-012024-06-30 06837467core:IntangibleAssetsOtherThanGoodwill2023-06-30 06837467core:IntangibleAssetsOtherThanGoodwill2024-06-30 06837467core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-30 06837467core:MotorVehicles2023-06-30 06837467core:FurnitureFittings2023-06-30 06837467core:ComputerEquipment2023-06-30 06837467core:MotorVehicles2023-07-012024-06-30 06837467core:MotorVehicles2024-06-30 06837467core:FurnitureFittings2024-06-30 06837467core:ComputerEquipment2024-06-30 068374672022-07-012023-06-30 iso4217:GBP xbrli:pure
Company Registration No. 06837467 (England and Wales)
PROPHARMACE LTD Unaudited accounts for the year ended 30 June 2024
PROPHARMACE LTD Unaudited accounts Contents
Page
- 2 -
PROPHARMACE LTD Company Information for the year ended 30 June 2024
Directors
Mr Modar Al Ahmad Mrs Noma Al-Ahmad
Company Number
06837467 (England and Wales)
Registered Office
47-49 PARK ROYAL ROAD LONDON NW10 7LQ
- 3 -
PROPHARMACE LTD Statement of financial position as at 30 June 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
755 
1,510 
Tangible assets
75,407 
39,393 
76,162 
40,903 
Current assets
Debtors
791 
791 
Cash at bank and in hand
1,478,708 
1,269,132 
1,479,499 
1,269,923 
Creditors: amounts falling due within one year
(111,656)
(58,938)
Net current assets
1,367,843 
1,210,985 
Net assets
1,444,005 
1,251,888 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
1,443,905 
1,251,788 
Shareholders' funds
1,444,005 
1,251,888 
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 26 March 2025 and were signed on its behalf by
Mr Modar Al Ahmad Director Company Registration No. 06837467
- 4 -
PROPHARMACE LTD Notes to the Accounts for the year ended 30 June 2024
1
Statutory information
PROPHARMACE LTD is a private company, limited by shares, registered in England and Wales, registration number 06837467. The registered office is 47-49 PARK ROYAL ROAD, LONDON, NW10 7LQ.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
Reducing Balance 20%
Fixtures & fittings
Reducing Balance 20%
Computer equipment
Reducing Balance 20%
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other 
£ 
Cost
At 1 July 2023
11,519 
At 30 June 2024
11,519 
Amortisation
At 1 July 2023
10,009 
Charge for the year
755 
At 30 June 2024
10,764 
Net book value
At 30 June 2024
755 
At 30 June 2023
1,510 
- 5 -
PROPHARMACE LTD Notes to the Accounts for the year ended 30 June 2024
5
Tangible fixed assets
Motor vehicles 
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At 1 July 2023
35,000 
7,202 
49,455 
91,657 
Additions
82,671 
- 
- 
82,671 
Disposals
(35,000)
- 
- 
(35,000)
At 30 June 2024
82,671 
7,202 
49,455 
139,328 
Depreciation
At 1 July 2023
7,187 
4,952 
40,125 
52,264 
Charge for the year
16,534 
450 
1,860 
18,844 
On disposals
(7,187)
- 
- 
(7,187)
At 30 June 2024
16,534 
5,402 
41,985 
63,921 
Net book value
At 30 June 2024
66,137 
1,800 
7,470 
75,407 
At 30 June 2023
27,813 
2,250 
9,330 
39,393 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
791 
791 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
1,095 
- 
VAT
14,064 
8,220 
Trade creditors
- 
1,099 
Taxes and social security
79,899 
38,025 
Other creditors
8,808 
8,478 
Loans from directors
5,390 
2,816 
Accruals
2,400 
300 
111,656 
58,938 
8
Average number of employees
During the year the average number of employees was 9 (2023: 9).
- 6 -